BRIDGEWATER, N.J., July 16, 2024 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical…
Engineered for precision, confidence and efficiency in surgery - and compatible with the CORI◊ Surgical System Smith+Nephew (LSE:SN, NYSE:SNN), the…
DURHAM, N.C., July 16, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable,…
Webcast and Conference Call to Be Held Tuesday, July 30, 2024, at 8:30 a.m. ETWALTHAM, Mass., July 16, 2024 (GLOBE…
Funds to be used for clinical development of EscharEx® to treat diabetic foot ulcers (DFUs) Award advances MediWound’s DFU program…
Central AI-Immunology™ Building Block: Evaxion’s proprietary in-house developed building block, EvaxMHC, is used across the AI-Immunology™ platform Improved Performance: Utilizing…
DC-based Children’s health system expands utilization of RevID to improve charge capture and financial performance, extends to 5-year termATLANTA, July…
Late Breaking Clinical Trial Presentations to Feature Additional Results from SEQUOIA-HCM Related to Patient-Reported Health Status, Cardiac Structure and Function and…
- Results will be presented at the London International Cough Symposium on July 18, 2024 - Dose dependent cough suppression…
Composition of matter patent approval underscores the Company’s solid-form technology to maximize future value and ability to strengthen and broaden…